— Know what they know.
Not Investment Advice

RDNT NASDAQ

RadNet, Inc.
1W: +1.9% 1M: -5.9% 3M: -22.3% YTD: -23.3% 1Y: -9.5% 3Y: +97.0% 5Y: +131.5%
$54.40
-0.04 (-0.07%)
 
Weekly Expected Move ±5.0%
$47 $50 $52 $55 $58
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Sell · Power 32 · $4.3B mcap · 70M float · 1.28% daily turnover · Short 72% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
40.7 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 2.4%  ·  5Y Avg: 0.8%
Cost Advantage ★
67
Intangibles
18
Switching Cost
42
Network Effect
42
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RDNT shows a Weak competitive edge (40.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 2.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$65
Low
$65
Avg Target
$65
High
Based on 1 analyst since May 11, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 8Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$78.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-20 Barclays Andrew Mok $79 $65 -14 +21.8% $53.35
2026-03-03 Jefferies Brian Tanquilut $100 $91 -9 +26.4% $72.01
2026-01-09 UBS Initiated $92 +17.4% $78.38
2026-01-08 KeyBanc Initiated $92 +17.4% $78.38
2025-12-17 Truist Financial David MacDonald $81 $90 +9 +26.4% $71.22
2025-11-14 Raymond James John Ransom Initiated $95 +29.3% $73.46
2025-09-03 Truist Financial $74 $81 +7 +14.2% $70.95
2025-07-10 Truist Financial David MacDonald $88 $74 -14 +29.2% $57.28
2025-01-22 Truist Financial David MacDonald $94 $88 -6 +42.5% $61.77
2024-12-05 Jefferies Brian Tanquilut $80 $100 +20 +26.3% $79.16
2024-11-29 Truist Financial David MacDonald $80 $94 +14 +12.6% $83.50
2024-09-23 Truist Financial David MacDonald $63 $80 +17 +14.4% $69.96
2024-09-19 Jefferies Brian Tanquilut Initiated $80 +19.2% $67.11
2024-09-06 Barclays Andrew Mok $57 $79 +22 +25.0% $63.19
2024-08-08 Barclays Andrew Mok Initiated $57 +0.2% $56.89
2024-05-15 Truist Financial David MacDonald $55 $63 +8 +11.1% $56.73
2024-03-28 Truist Financial David MacDonald Initiated $55 +13.4% $48.49
2023-06-26 Needham Quinn Bolton Initiated $37 +12.1% $33.02

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RDNT receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-03-05 C D+
2026-03-02 D+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

35 Grade D
Profitability
0
Balance Sheet
48
Earnings Quality
53
Growth
79
Value
28
Momentum
74
Safety
50
Cash Flow
12
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RDNT scores highest in Growth (79/100) and lowest in Profitability (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.84
Grey Zone
Piotroski F-Score
5/9
Beneish M-Score
-4.69
Unlikely Manipulator
Ohlson O-Score
-6.74
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB-
Score: 39.8/100
Trend: Stable
Earnings Quality
OCF/NI: -24.63x
Accruals: -10.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RDNT scores 1.84, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RDNT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RDNT's score of -4.69 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RDNT's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RDNT receives an estimated rating of BB- (score: 39.8/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-295.37x
PEG
-13.04x
P/S
1.99x
P/B
3.88x
P/FCF
-28.96x
P/OCF
12.32x
EV/EBITDA
16.72x
EV/Revenue
2.52x
EV/EBIT
53.28x
EV/FCF
-36.29x
Earnings Yield
-0.33%
FCF Yield
-3.45%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. RDNT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
-0.441
NI / EBT
×
Interest Burden
0.318
EBT / EBIT
×
EBIT Margin
0.047
EBIT / Rev
×
Asset Turnover
0.609
Rev / Assets
×
Equity Multiplier
3.536
Assets / Equity
=
ROE
-1.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RDNT's ROE of -1.4% is driven by financial leverage (equity multiplier: 3.54x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of -0.44 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$54.40
Median 1Y
$58.50
5th Pctile
$24.60
95th Pctile
$139.25
Ann. Volatility
52.5%
Analyst Target
$78.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Howard G. Berger,
M.D. President and Chief Executive Officer (principal executive officer)
$3,000,000 $8,999,966 $12,087,934
Stephen M. Forthuber
President and Chief Operating Officer - Eastern Operations
$800,000 $1,999,952 $3,254,446
Norman R. Hames
President and Chief Operating Officer - Western Operations
$800,000 $1,999,952 $3,238,056
Mital Patel
Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer
$750,000 $1,874,960 $3,055,554
Mark D. Stolper
Executive Vice President and Chief Financial Officer (principal financial officer)
$700,000 $1,749,967 $2,833,489

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
8,844
+3.5% YoY
Revenue / Employee
$230,689
Rev: $2,040,210,000
Profit / Employee
$-2,109
NI: $-18,652,000
SGA / Employee
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 15.4% 21.7% 12.5% 9.3% 11.8% 3.9% 3.8% -4.8% -4.6% 1.4% 0.6% 4.4% 2.1% -0.9% 0.4% -4.2% -1.9% -1.7% -1.9% -1.4% -1.42%
ROA 1.4% 2.0% 1.3% 1.0% 1.2% 0.4% 0.5% -0.6% -0.6% 0.2% 0.1% 0.8% 0.4% -0.2% 0.1% -1.1% -0.5% -0.4% -0.5% -0.4% -0.40%
ROIC 5.1% 5.9% 4.2% 3.3% 2.9% 1.5% 2.1% 1.7% 2.4% 4.2% 4.3% 5.2% 5.3% 5.0% 4.8% 1.6% 3.0% 2.5% 1.7% 2.4% 2.41%
ROCE 7.8% 8.8% 6.4% 5.8% 6.2% 5.1% 4.8% 3.8% 3.9% 5.2% 4.6% 5.3% 5.6% 5.1% 4.3% 3.0% 3.2% 3.3% 3.2% 3.2% 3.19%
Gross Margin 15.1% 18.0% 14.6% 7.8% 13.7% 10.3% 14.1% 9.9% 14.5% 15.0% 15.2% 10.2% 15.2% 15.0% 13.8% 3.8% 13.9% 13.9% 13.9% -2.8% -2.85%
Operating Margin 8.3% 9.8% 1.4% -0.5% 5.5% 2.0% 5.6% 1.7% 6.1% 10.8% 5.8% 2.6% 7.6% 7.4% 5.1% -5.1% 6.2% 5.2% 6.4% -2.8% -2.85%
Net Margin 0.9% 4.9% -1.1% 0.9% 2.2% 0.2% -0.2% -5.4% 2.1% 4.4% -0.4% -0.6% -0.6% 0.7% 1.1% -8.0% 2.9% 1.0% -0.1% -5.8% -5.81%
EBITDA Margin 19.8% 24.7% 17.6% 19.1% 21.1% 19.4% 18.4% 12.7% 19.3% 19.8% 16.6% 12.1% 15.2% 15.4% 13.8% 4.2% 15.5% 14.8% 25.5% 5.0% 4.96%
FCF Margin 6.3% 4.6% -0.7% -3.1% -0.9% -1.4% -7.2% -6.1% -5.3% -5.8% 3.3% 2.2% 4.0% 5.3% 2.5% 4.2% 4.0% 2.6% -8.7% -6.9% -6.94%
OCF Margin 12.8% 12.6% 11.4% 9.1% 11.5% 10.3% 10.2% 12.0% 11.9% 11.7% 13.7% 12.4% 14.8% 15.8% 12.7% 13.8% 13.7% 13.1% 14.6% 16.3% 16.30%
ROE 3Y Avg snapshot only -0.51%
ROE 5Y Avg snapshot only 0.49%
ROA 3Y Avg snapshot only -0.19%
ROIC 3Y Avg snapshot only 0.87%
ROIC Economic snapshot only 1.81%
Cash ROA snapshot only 9.30%
Cash ROIC snapshot only 16.03%
CROIC snapshot only -6.82%
NOPAT Margin snapshot only 2.46%
Pretax Margin snapshot only 1.50%
R&D / Revenue snapshot only 0.17%
SGA / Revenue snapshot only 1.44%
SBC / Revenue snapshot only 1.22%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 73.23 45.71 65.71 68.96 42.22 151.13 100.84 -108.05 -154.00 488.72 775.64 158.56 436.12 -1182.17 1888.85 -114.31 -282.57 -447.93 -287.63 -303.46 -295.374
P/S Ratio 1.43 1.22 1.24 0.94 0.72 0.85 0.75 0.98 1.30 1.23 1.46 2.03 2.52 2.94 2.88 1.98 2.21 2.89 2.63 2.01 1.995
P/B Ratio 10.80 9.52 7.10 5.51 4.30 5.13 3.23 4.34 5.97 5.83 3.74 5.35 6.86 8.27 5.85 4.10 4.67 6.31 4.92 3.95 3.879
P/FCF 22.73 26.33 -181.77 -29.84 -76.23 -62.57 -10.43 -15.93 -24.49 -21.06 43.80 91.43 63.66 55.37 117.35 47.46 55.46 109.36 -30.07 -28.96 -28.956
P/OCF 11.17 9.68 10.87 10.31 6.29 8.26 7.34 8.11 10.96 10.45 10.69 16.42 17.08 18.67 22.64 14.37 16.10 22.14 17.95 12.32 12.319
EV/EBITDA 10.66 9.22 10.37 9.27 8.00 9.14 8.83 10.77 12.68 11.97 12.68 16.18 20.18 24.22 24.20 20.71 22.30 27.87 20.57 16.72 16.724
EV/Revenue 2.30 2.06 2.20 1.88 1.65 1.77 1.72 1.91 2.21 2.10 2.17 2.73 3.19 3.59 3.42 2.51 2.73 3.39 3.16 2.52 2.517
EV/EBIT 26.46 21.82 26.81 25.71 21.68 28.24 26.22 37.77 44.21 32.40 33.98 37.51 43.44 55.51 51.76 54.93 57.26 72.24 63.41 53.28 53.279
EV/FCF 36.48 44.41 -323.09 -59.73 -174.05 -129.95 -23.88 -31.22 -41.57 -36.10 65.10 122.57 80.57 67.57 139.34 60.15 68.47 128.36 -36.19 -36.29 -36.295
Earnings Yield 1.4% 2.2% 1.5% 1.5% 2.4% 0.7% 1.0% -0.9% -0.6% 0.2% 0.1% 0.6% 0.2% -0.1% 0.1% -0.9% -0.4% -0.2% -0.3% -0.3% -0.33%
FCF Yield 4.4% 3.8% -0.6% -3.4% -1.3% -1.6% -9.6% -6.3% -4.1% -4.7% 2.3% 1.1% 1.6% 1.8% 0.9% 2.1% 1.8% 0.9% -3.3% -3.5% -3.45%
Price/Tangible Book snapshot only 127.725
EV/OCF snapshot only 15.441
EV/Gross Profit snapshot only 26.835
Acquirers Multiple snapshot only 70.152
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.68 0.68 0.87 0.87 0.87 0.87 0.79 0.79 0.79 0.79 1.32 1.32 1.32 1.32 2.12 2.12 2.12 2.12 1.76 1.76 1.759
Quick Ratio 0.68 0.68 0.87 0.87 0.87 0.87 0.79 0.79 0.79 0.79 1.32 1.32 1.32 1.32 2.12 2.12 2.12 2.12 1.76 1.76 1.759
Debt/Equity 7.15 7.15 6.11 6.11 6.11 6.11 4.55 4.55 4.55 4.55 2.36 2.36 2.36 2.36 1.92 1.92 1.92 1.92 1.71 1.71 1.706
Net Debt/Equity 6.53 6.53 5.52 5.52 5.52 5.52 4.16 4.16 4.16 4.16 1.82 1.82 1.82 1.82 1.10 1.10 1.10 1.10 1.00 1.00 1.002
Debt/Assets 0.66 0.66 0.68 0.68 0.68 0.68 0.62 0.62 0.62 0.62 0.55 0.55 0.55 0.55 0.53 0.53 0.53 0.53 0.49 0.49 0.495
Debt/EBITDA 4.40 4.11 5.02 5.13 4.98 5.24 5.43 5.76 5.69 5.45 5.39 5.34 5.50 5.68 6.68 7.64 7.41 7.21 5.92 5.76 5.758
Net Debt/EBITDA 4.02 3.75 4.54 4.64 4.50 4.74 4.97 5.27 5.21 4.99 4.15 4.11 4.23 4.37 3.82 4.37 4.24 4.12 3.48 3.38 3.382
Interest Coverage 2.24 2.46 2.61 2.45 2.64 2.17 1.85 1.36 1.28 1.62 1.60 1.85 1.68 1.46 1.52 1.06 1.26 1.32 1.46 1.44 1.441
Equity Multiplier 10.78 10.78 8.99 8.99 8.99 8.99 7.31 7.31 7.31 7.31 4.27 4.27 4.27 4.27 3.64 3.64 3.64 3.64 3.45 3.45 3.449
Cash Ratio snapshot only 1.308
Debt Service Coverage snapshot only 4.590
Cash to Debt snapshot only 0.413
FCF to Debt snapshot only -0.080
Defensive Interval snapshot only 2843.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.73 0.75 0.68 0.70 0.71 0.72 0.64 0.66 0.68 0.70 0.63 0.65 0.67 0.69 0.61 0.63 0.64 0.66 0.58 0.61 0.609
Inventory Turnover 1048.62 1074.39
Receivables Turnover 8.78 9.07 9.94 10.14 10.29 10.42 9.49 9.81 10.14 10.48 9.80 10.05 10.38 10.74 10.47 10.70 10.92 11.27 10.57 11.11 11.107
Payables Turnover 15.93 16.32 14.35 14.77 15.05 15.58 13.37 13.76 14.18 14.47 12.37 12.69 13.08 13.53 14.41 15.01 15.37 15.91 6.96 7.50 7.496
DSO 42 40 37 36 35 35 38 37 36 35 37 36 35 34 35 34 33 32 35 33 32.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 23 22 25 25 24 23 27 27 26 25 30 29 28 27 25 24 24 23 52 49 48.7 days
Cash Conversion Cycle 19 18 11 11 11 12 11 11 10 10 8 8 7 7 10 10 10 9 -18 -16 -15.8 days
Fixed Asset Turnover snapshot only 0.716
Cash Velocity snapshot only 2.795
Capital Intensity snapshot only 1.753
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 17.2% 21.1% 22.7% 21.3% 9.1% 6.9% 8.7% 10.2% 12.2% 14.6% 13.0% 12.1% 12.1% 12.2% 13.2% 12.8% 11.3% 11.1% 11.5% 14.7% 14.72%
Net Income 2.8% 4.3% 2.7% 66.6% -4.6% -77.5% -56.9% -1.7% -1.6% -48.9% -71.4% 2.6% 1.8% -2.1% -8.2% -2.5% -2.5% -1.9% -7.7% 56.1% 56.14%
EPS 2.7% 4.2% 2.6% 56.1% -11.0% -79.0% -59.3% -1.7% -1.5% -57.2% -76.0% 2.3% 1.6% -2.0% -17.5% -2.4% -2.5% -1.9% -7.7% 57.7% 57.66%
FCF -37.5% -54.5% -1.1% -1.3% -1.2% -1.3% -10.5% -1.1% -5.3% -3.9% 1.5% 1.4% 1.8% 2.0% -16.6% 1.1% 11.9% -44.7% -5.0% -2.9% -2.91%
EBITDA 43.0% 47.9% 39.4% 14.0% 4.3% -7.6% 0.1% -3.5% -5.3% 4.3% -0.6% 6.4% 2.0% -5.5% -6.5% -19.0% -14.0% -8.7% 21.2% 42.7% 42.65%
Op. Income 1.8% 1.6% 1.3% 1.7% -38.6% -70.2% -43.8% -13.3% 8.3% 2.3% 1.1% 88.8% 90.8% 8.8% 6.0% -33.1% -42.7% -43.8% -33.8% 11.2% 11.23%
OCF Growth snapshot only 35.81%
Asset Growth snapshot only 14.36%
Equity Growth snapshot only 20.79%
Debt Growth snapshot only 7.52%
Shares Change snapshot only 3.60%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 10.0% 10.6% 10.5% 9.7% 8.7% 7.5% 7.4% 8.3% 12.8% 14.1% 14.7% 14.5% 11.1% 11.2% 11.6% 11.7% 11.9% 12.6% 12.6% 13.2% 13.19%
Revenue 5Y 7.8% 8.1% 8.3% 8.4% 8.4% 8.6% 9.2% 9.8% 10.2% 10.6% 10.6% 10.3% 10.1% 9.8% 9.7% 9.9% 12.4% 13.1% 13.7% 14.2% 14.17%
EPS 3Y -11.0% -23.5% -16.6% -41.3% -13.8% 13.9% -33.5% -56.8%
EPS 5Y 14.9% 46.3% 24.1% 14.3% 15.4% -10.3% 1.8% -41.4% -15.8% -28.1% -33.8%
Net Income 3Y -8.5% -20.1% -12.9% -38.6% -10.3% 24.7% -26.0% -51.7%
Net Income 5Y 17.8% 50.8% 27.9% 18.7% 19.9% -6.7% 1.9% -37.6% -9.9% -22.4% -28.3%
EBITDA 3Y 32.8% 34.3% 37.3% 25.8% 20.1% 13.0% 7.3% 7.3% 12.2% 12.5% 11.5% 5.4% 0.2% -3.1% -2.4% -6.0% -6.0% -3.5% 4.1% 7.1% 7.10%
EBITDA 5Y 20.2% 22.1% 20.5% 19.1% 18.4% 17.7% 18.4% 18.6% 18.3% 18.5% 20.8% 15.4% 10.8% 7.3% 2.8% 1.2% 4.4% 4.2% 9.5% 6.2% 6.21%
Gross Profit 3Y 15.9% 17.6% 21.3% 15.5% 12.7% 6.3% 2.4% 8.2% 26.0% 28.1% 27.9% 22.0% 10.0% 8.5% 9.1% 6.3% 6.5% 12.1% 12.4% 4.2% 4.22%
Gross Profit 5Y 11.3% 13.3% 12.0% 10.5% 9.0% 6.4% 6.7% 9.7% 10.3% 12.2% 15.5% 13.5% 13.1% 13.2% 10.0% 9.7% 18.8% 17.4% 17.3% 10.0% 10.01%
Op. Income 3Y 26.6% 25.7% 38.8% 17.4% 6.8% -13.6% -12.8% 0.6% 23.0% 35.5% 40.4% 18.5% 8.3% 1.9% 8.2% 3.1% 5.8% 25.9% 14.3% 12.0% 12.01%
Op. Income 5Y 18.3% 23.8% 16.5% 8.4% 2.6% -8.8% -1.5% 5.2% 6.2% 14.1% 26.2% 21.5% 20.3% 18.0% 8.4% 5.1% 15.3% 8.8% 14.2% 4.4% 4.38%
FCF 3Y 23.0% -0.2% -28.0% -38.3% -4.8% 16.3%
FCF 5Y 8.3% 26.3% -9.6% -16.9%
OCF 3Y 5.1% 2.0% 8.6% 0.8% 11.0% 8.4% 12.0% 14.6% -1.8% -1.1% -1.8% -2.3% 16.5% 19.7% 15.9% 28.2% 18.7% 21.9% 26.8% 25.2% 25.20%
OCF 5Y 12.1% 14.8% 10.3% 3.8% 11.6% 4.8% 0.7% 5.8% 5.6% 3.9% 13.6% 11.5% 17.2% 20.2% 17.4% 16.8% 6.5% 6.0% 5.1% 9.7% 9.69%
Assets 3Y 27.2% 27.2% 22.9% 22.9% 22.9% 22.9% 13.9% 13.9% 13.9% 13.9% 14.6% 14.6% 14.6% 14.6% 16.9% 16.9% 16.9% 16.9% 15.6% 15.6% 15.59%
Assets 5Y 16.3% 16.3% 19.4% 19.4% 19.4% 19.4% 22.9% 22.9% 22.9% 22.9% 19.4% 19.4% 19.4% 19.4% 14.8% 14.8% 14.8% 14.8% 16.0% 16.0% 16.04%
Equity 3Y 39.1% 39.1% 21.6% 21.6% 21.6% 21.6% 30.0% 30.0% 30.0% 30.0% 56.1% 56.1% 56.1% 56.1% 58.0% 58.0% 58.0% 58.0% 48.5% 48.5% 48.47%
Book Value 3Y 35.0% 34.5% 18.2% 16.5% 16.6% 16.3% 24.9% 24.1% 22.2% 18.3% 43.0% 42.6% 40.2% 39.7% 41.2% 44.0% 44.7% 44.9% 35.4% 34.8% 34.83%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.90 0.85 0.82 0.86 0.93 0.90 0.87 0.90 0.96 0.94 0.94 0.93 0.97 0.95 0.95 0.96 1.00 1.00 1.00 0.99 0.993
Earnings Stability 0.01 0.12 0.01 0.07 0.10 0.03 0.00 0.06 0.01 0.00 0.15 0.13 0.11 0.24 0.01 0.20 0.06 0.17 0.09 0.36 0.364
Margin Stability 0.83 0.84 0.85 0.92 0.83 0.84 0.86 0.92 0.83 0.83 0.84 0.91 0.93 0.89 0.92 0.92 0.83 0.85 0.87 0.87 0.867
Rev. Growth Consistency 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.20 0.80 0.50 0.20 0.20 0.20 0.97 0.20 0.20 0.50 0.20 0.50 0.500
Earnings Smoothness 0.50 0.95 0.00 0.20 0.35 0.00 0.91
ROE Trend 0.05 0.11 0.10 0.04 0.07 -0.04 0.02 -0.11 -0.16 -0.11 -0.07 0.01 -0.02 -0.03 -0.02 -0.03 -0.01 -0.02 -0.02 -0.01 -0.012
Gross Margin Trend 0.04 0.04 0.03 0.02 0.02 -0.01 -0.01 -0.01 -0.02 0.00 0.01 0.01 0.01 0.01 0.01 -0.01 -0.01 -0.02 -0.02 -0.03 -0.034
FCF Margin Trend 0.03 0.01 -0.09 -0.11 -0.10 -0.10 -0.14 -0.12 -0.08 -0.07 0.07 0.07 0.07 0.09 0.04 0.06 0.05 0.03 -0.12 -0.10 -0.101
Sustainable Growth Rate 15.4% 21.7% 12.5% 9.3% 11.8% 3.9% 3.8% 1.4% 0.6% 4.4% 2.1% 0.4%
Internal Growth Rate 1.4% 2.1% 1.3% 1.0% 1.2% 0.4% 0.5% 0.2% 0.1% 0.8% 0.4% 0.1%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 6.56 4.72 6.05 6.69 6.71 18.29 13.75 -13.33 -14.06 46.76 72.56 9.65 25.53 -63.33 83.43 -7.96 -17.55 -20.23 -16.02 -24.63 -24.634
FCF/OCF 0.49 0.37 -0.06 -0.35 -0.08 -0.13 -0.70 -0.51 -0.45 -0.50 0.24 0.18 0.27 0.34 0.19 0.30 0.29 0.20 -0.60 -0.43 -0.425
FCF/Net Income snapshot only 10.480
OCF/EBITDA snapshot only 1.083
CapEx/Revenue 6.5% 8.0% 12.0% 12.3% 12.4% 11.7% 17.4% 18.2% 17.2% 17.6% 10.3% 10.2% 10.8% 10.4% 10.3% 9.6% 9.7% 10.4% 23.4% 23.2% 23.24%
CapEx/Depreciation snapshot only 2.250
Accruals Ratio -0.08 -0.07 -0.06 -0.05 -0.07 -0.07 -0.06 -0.09 -0.09 -0.08 -0.09 -0.07 -0.09 -0.11 -0.08 -0.10 -0.09 -0.09 -0.09 -0.10 -0.103
Sloan Accruals snapshot only -0.090
Cash Flow Adequacy snapshot only 0.702
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% 0.0% -12.4% -12.7% -10.4% -13.8% -5.0% -4.2% -4.1% -0.0% 0.0% 0.0% -0.1% -0.1% -0.08%
Total Shareholder Return -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% 0.0% -12.4% -12.7% -10.4% -13.8% -5.0% -4.2% -4.1% -0.0% 0.0% 0.0% -0.1% -0.1% -0.08%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.41 0.48 0.42 0.36 0.41 0.20 0.25 -0.67 -0.77 0.10 0.08 0.38 0.19 -0.12 0.06 -3.95 -0.66 -0.48 -0.58 -0.44 -0.441
Interest Burden (EBT/EBIT) 0.55 0.59 0.55 0.52 0.55 0.45 0.46 0.27 0.22 0.38 0.38 0.46 0.40 0.32 0.37 0.10 0.25 0.28 0.31 0.32 0.318
EBIT Margin 0.09 0.09 0.08 0.07 0.08 0.06 0.07 0.05 0.05 0.06 0.06 0.07 0.07 0.06 0.07 0.05 0.05 0.05 0.05 0.05 0.047
Asset Turnover 0.73 0.75 0.68 0.70 0.71 0.72 0.64 0.66 0.68 0.70 0.63 0.65 0.67 0.69 0.61 0.63 0.64 0.66 0.58 0.61 0.609
Equity Multiplier 10.81 10.81 9.74 9.74 9.74 9.74 7.99 7.99 7.99 7.99 5.32 5.32 5.32 5.32 3.90 3.90 3.90 3.90 3.54 3.54 3.536
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.46 $0.64 $0.46 $0.32 $0.41 $0.13 $0.19 $-0.23 $-0.21 $0.06 $0.04 $0.31 $0.14 $-0.06 $0.04 $-0.43 $-0.20 $-0.17 $-0.25 $-0.18 $-0.18
Book Value/Share $3.12 $3.08 $4.24 $4.06 $4.02 $3.97 $5.84 $5.77 $5.47 $4.84 $9.29 $9.10 $8.59 $8.39 $11.95 $12.13 $12.18 $12.08 $14.50 $14.14 $17.55
Tangible Book/Share $-6.77 $-6.68 $-6.33 $-6.06 $-6.00 $-5.92 $-7.90 $-7.81 $-7.40 $-6.55 $-2.05 $-2.01 $-1.90 $-1.85 $1.46 $1.48 $1.49 $1.48 $0.45 $0.44 $0.44
Revenue/Share $23.51 $23.97 $24.37 $23.80 $23.91 $23.93 $25.07 $25.63 $25.09 $22.96 $23.81 $23.92 $23.34 $23.59 $24.22 $25.13 $25.76 $26.37 $27.13 $27.83 $27.83
FCF/Share $1.48 $1.11 $-0.17 $-0.75 $-0.23 $-0.33 $-1.81 $-1.57 $-1.33 $-1.34 $0.79 $0.53 $0.93 $1.25 $0.60 $1.05 $1.03 $0.70 $-2.37 $-1.93 $-1.93
OCF/Share $3.02 $3.03 $2.77 $2.17 $2.75 $2.46 $2.57 $3.09 $2.98 $2.70 $3.25 $2.96 $3.45 $3.72 $3.08 $3.46 $3.53 $3.44 $3.97 $4.54 $4.54
Cash/Share $1.92 $1.90 $2.49 $2.39 $2.36 $2.33 $2.24 $2.22 $2.10 $1.86 $5.04 $4.94 $4.67 $4.56 $9.80 $9.95 $9.99 $9.91 $10.20 $9.96 $5.91
EBITDA/Share $5.07 $5.36 $5.16 $4.83 $4.93 $4.62 $4.88 $4.55 $4.37 $4.04 $4.08 $4.03 $3.70 $3.50 $3.43 $3.04 $3.15 $3.21 $4.17 $4.19 $4.19
Debt/Share $22.30 $22.02 $25.90 $24.80 $24.54 $24.25 $26.53 $26.23 $24.84 $21.99 $21.96 $21.51 $20.31 $19.84 $22.89 $23.24 $23.34 $23.14 $24.72 $24.12 $24.12
Net Debt/Share $20.38 $20.12 $23.41 $22.41 $22.17 $21.91 $24.29 $24.01 $22.75 $20.14 $16.91 $16.57 $15.64 $15.28 $13.09 $13.29 $13.35 $13.24 $14.52 $14.17 $14.17
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.842
Altman Z-Prime snapshot only 2.758
Piotroski F-Score 7 7 7 7 6 5 4 5 5 6 7 8 8 6 6 5 5 6 6 5 5
Beneish M-Score -3.20 -2.96 -2.66 -2.49 -2.69 -2.35 -2.35 -2.58 -2.51 -2.62 -2.87 -2.80 -2.73 -2.95 -2.58 -1.83 -2.65 -2.65 -3.43 -4.69 -4.691
Ohlson O-Score snapshot only -6.741
ROIC (Greenblatt) snapshot only 2.94%
Net-Net WC snapshot only $-17.79
EVA snapshot only $-165478217.29
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 25.57 25.41 24.80 20.69 21.89 21.64 17.55 15.51 19.79 21.98 32.75 38.78 39.68 37.99 43.75 40.65 41.56 40.37 39.92 39.82 39.822
Credit Grade snapshot only 13
Credit Trend snapshot only -0.831
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 34
Sector Credit Rank snapshot only 30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms